---

$13.96

-0.4700 ( -3.26% ) 345.2K

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-12-20	Sale	-386.00	Jones Jeffrey Alan
2023-12-20	Sale	-290.00	SUMER JACQUELYN L
2023-12-20	Sale	-398.00	Trigilio Jeffrey
2023-12-13	Sale	-1926.00	Trigilio Jeffrey
2023-12-13	Sale	-1068.00	Michaelson Jennifer